The MEK-Inhibitor Selumetinib Attenuates Tumor Growth and Reduces IL-6 Expression but Does Not Protect against Muscle Wasting in Lewis Lung Cancer Cachexia

Ernie D. Au(Indiana University School of Medicine), Teresa A. Zimmers(Oregon Health & Science University)
Frontiers in Physiology
January 18, 2017
Cited by 28


Related Papers